Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 6 39-6, 1996, Pages

  Stein, Birgitt ^a   Bartel, Sabine ^b   Kirchhefer, Uwe ^b   Kokott, Sabine ^b   Krause, Ernst Georg ^b   Neumann, Joachim ^b   Schmitz, Wilhelm ^b   Scholz, Hasso ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

adenosinetriphosphata se; calcium; contractility; heart; hypertrophy; phosphoproteins

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CYCLIC AMP; ISOPRENALINE; PHOSPHOLAMBAN; PHOSPHOPROTEIN;

ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SARCOPLASMIC RETICULUM;

EID: 33750813323     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.6.h2021     Document Type: Article

References (30)

1. Arai, M., M. H. Matsui, and M. Periasamy. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ. Res. 74: 463-469, 1994.
2. 2+ ATPase gene in pressure overload-induced cardiac hypertrophy. Circ. Res. 66: 554-564, 1990.
3. Beuckelmann, D. J., M. Näbauer, and E. Erdmann. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 88: 1045-1055, 1992.
4. Bowling, N. L., J. S. Hayes, and L. R. Jones. Down-regulation of cardiac phospholamban in response to chronic β-adrenoceptor stimulation (Abstract). Circulation 80, Suppl. II: II-292, 1989.
5. Buxton, I. L. O., and L. B. Brunton. Compartments of cyclic AMP and protein kinase in mammalian myocytes. J. Biol. Chem. 258: 10233-10239, 1983.
6. Edes, I., and E. G. Kranias. Regulation of cardiac sarcoplasmic reticulum function by phospholamban. Membr. Biochem. 7: 175-192, 1989.
7. Gwathmey, J. K., L. Copelas, R. MacKinnon, P. J. Schoen, M. D. Feldman, W. Grossman, and J. P. Morgan. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ. Res. 61: 70-76, 1987.
8. Hayes, J. S., V. L. Wyss, K. S. Schenck, and M. L. Cohen. Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists. J. Pharmacol. Exp. Ther. 237: 757-763, 1986.
9. 2+ activation. J. Physiol. Lond. 439: 701-715, 1993.
10. Jones, S. M., N. A. Hunt, F. del Monte, and S. E. Harding. Contraction of cardiac myocytes from noradrenaline-treated rats in response to isoprenaline, forskolin and dibutyryl cAMP. Eur. J. Pharmacol. 191: 129-140, 1990.
11. Karczewski, P., S. Bartel, and E. G. Krause. Differential sensitivity to isoproterenol of phospholamban and troponin I phosphorylation in isolated rat hearts. Biochem. J. 266: 115-122, 1990.
12. Kiss, E., G. Jakab, E. G. Kranias, and I. Edes. Thyroid hormone-induced alterations in phospholamban protein expression. Circ. Res. 75: 245-251, 1994.
13. 2+-ATPase activity in guinea pig ventricles. J. Biol. Chem. 258: 464-471, 1983.
14. Luo, W., I. L. Grupp, J. Harrer, S. Ponniah, G. Grupp, J. J. Duffy, T. Doetschman, and E. G. Kranias. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ. Res. 75: 401-409, 1994.
15. Meinertz, T., H. Nawrath, H. Scholz, and K. Winter. Effect of DB-cAMP on mechanical characteristics of ventricular and atrial preparations of several mammalian species. Naunyn-Schmiedebergs Arch. Pharmacol. 282: 143-153, 1974.
16. Mende, U., T. Eschenhagen, B. Geertz, W. Schmitz, H. Scholz, J. Schulte am Esch, R. Sempell, and M. Steinfath. Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart. Naunyn-Schmiedebergs Arch. Pharmacol. 345: 23-50, 1992.
17. Morano, I., K. Hädicke, S. Grom, A. Koch, R. H. G. Schwinger, M. Böhm, S. Bartel, E. Erdmann, and E. G. Krause. Titin, myosin light chains and C-protein in developing and failing human heart. J. Mol. Cell. Cardiol 26: 361-368, 1994.
18. Murray, K. J., M. L. Reeves, and J. P. England. Protein phosphorylation and compartments of cyclic AMP in the cardiac contraction. Mol. Cell. Biochem. 89: 175-179, 1989.
19. Neumann, J., P. Boknik, G. Kaspareit, S. Bartel, E. G. Krause, H. T. Pask, W. Schmitz, and H. Scholz. Effects of the phosphatase inhibitor calyculin A on the phosphorylation of C-protein in mammalian ventricular cardiomyocytes. Biochem. Pharmacol. 49: 1583-1588, 1995.
20. Ray, K. P., and J. P. England. Phosphorylation of the inhibitory subunit of troponin and its effect on the calcium dependence of myofibril adenosine triphosphatases. FEBS Lett. 70: 11-16, 1976.
21. Reithmann, C., P. Gierschik, D. Sidiropoulos, K. Werdan, and K. H. Jakobs. Mechanism of noradrenaline-induced heterologous desenzitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein alpha-subunits. Eur. J. Pharmacol. 172: 211-221, 1989.
22. Reithmann, C., and K. Werdan. Noradrenaline-induced desensitization in cultured heart cells as a model for the defects of the adenylate cyclase system in severe heart failure. Naunyn-Schmiedebergs Arch. Pharmacol. 339: 138-144, 1989.
23. 2+-regulatory site of bovine cardiac troponin. J. Biol. Chem. 257: 260-263, 1982.
24. 2+ and phosphorylation in contraction of the heart. In: Protein Phosphorylation in Heart Muscle, edited by R. J. Solaro. Boca Raton, FL: CRC, 1987, p. 1-15.
25. Solaro, R. J. Modulation of activation of cardiac myofilaments by beta-adrenergic agonists. In: Modulation of Cardiac Calcium, edited by J. A. Lee and D. G. Allen. New York: Oxford Univ. Press, 1993, p. 160-177.
26. Stanton, H. C., G. Brenner, and E. D. Mayfield. Studies on isoproterenol-induced cardiomegaly in rats. Am. Heart J. 77: 72-80, 1969.
27. Tada, M., and A. M. Katz. Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu. Rev. Physiol. 44: 401-423, 1982.
28. Tse, J., J. R. Powell, C. A. Baste, R. E. Priest, and J. F. Kuo. Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of β-adrenergic receptor, adenylate cyclase, and ventricular contraction. Endocrinology 105: 246-254, 1979.
29. Von der Leyen, H., J. Neumann, M. Nose, W. Schmitz, H. Scholz, J. Starbatty, B. Stein, H. Wenzlaff, V. Döring, P. Kalmár, and A. Haverich. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations. Naunyn Schmiedebergs Arch. Pharmacol. 344: 90-100, 1991.
30. Wattanapennpool, J., X. Guo, and J. R. Solaro. The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated. J. Mol. Cell. Cardiol. 27: 1368-1391, 1995.